Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus.

Mok CC, Chan PT, To CH.

Arthritis Rheum. 2013 Jan;65(1):206-10. doi: 10.1002/art.37719.

2.

[Assessment of ovarian reserve with anti-Müllerian hormone in female patients with systemic lupus erythematosus].

Chen D, Yuan S, Zhan Z, Zhan Y, Yang X, Liang L.

Zhonghua Yi Xue Za Zhi. 2014 Apr 8;94(13):977-80. Chinese.

PMID:
24851682
3.

Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients.

Marder W, McCune WJ, Wang L, Wing JJ, Fisseha S, McConnell DS, Christman GM, Somers EC.

Gynecol Endocrinol. 2012 Aug;28(8):624-7. doi: 10.3109/09513590.2011.650752. Epub 2012 Feb 2.

4.

Brief Report: The Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen Does Not Impact the Ovarian Reserve, as Measured by Serum Levels of Anti-Müllerian Hormone.

Tamirou F, Husson SN, Gruson D, Debiève F, Lauwerys BR, Houssiau FA.

Arthritis Rheumatol. 2017 Jun;69(6):1267-1271. doi: 10.1002/art.40079. Epub 2017 May 3.

PMID:
28235250
5.

Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's).

Clowse ME, Copland SC, Hsieh TC, Chow SC, Hoffman GS, Merkel PA, Spiera RF, Davis JC Jr, McCune WJ, Ytterberg SR, St Clair EW, Allen NB, Specks U, Stone JH; WGET Research Group.

Arthritis Care Res (Hoboken). 2011 Dec;63(12):1777-81. doi: 10.1002/acr.20605.

6.

Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide.

Morel N, Bachelot A, Chakhtoura Z, Ghillani-Dalbin P, Amoura Z, Galicier L, Aumaitre O, Piette JC, Pourrat J, Boutin D, Sacre K, Kahn JE, Duhaut P, Farge D, Francès C, Guettrot-Imbert G, Harlé JR, Lambotte O, Le Guern V, Sène D, Trad S, Vidal E, Sarrot-Reynauld F, Gompel A, Tanguy ML, Touraine P, Lacorte JM, Costedoat-Chalumeau N; PLUS group.

J Clin Endocrinol Metab. 2013 Sep;98(9):3785-92. doi: 10.1210/jc.2013-1235. Epub 2013 Jul 5.

PMID:
23833039
7.

Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone.

Lawrenz B, Henes J, Henes M, Neunhoeffer E, Schmalzing M, Fehm T, Kïtter I.

Lupus. 2011 Oct;20(11):1193-7. doi: 10.1177/0961203311409272. Epub 2011 Jul 18.

PMID:
21768179
8.
9.

Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.

Akawatcharangura P, Taechakraichana N, Osiri M.

Lupus. 2016 Apr;25(4):436-44. doi: 10.1177/0961203315617539. Epub 2015 Nov 29.

PMID:
26621134
10.

Assessment of anti-Müllerian hormone levels in premenopausal patients with systemic lupus erythematosus.

Gasparin AA, Souza L, Siebert M, Xavier RM, Chakr RM, Palominos PE, Brenol JC, Monticielo OA.

Lupus. 2016 Mar;25(3):227-32. doi: 10.1177/0961203315598246. Epub 2015 Jul 28.

PMID:
26223296
11.

Anti-Müllerian hormone in reproductive age women with systemic lupus erythematosus.

Velarde-Ochoa Mdel C, Esquivel-Valerio JA, Vega-Morales D, Skinner-Taylor CM, Galarza-Delgado DÁ, Garza-Elizondo MA.

Reumatol Clin. 2015 Mar-Apr;11(2):78-82. doi: 10.1016/j.reuma.2014.03.009. Epub 2014 May 10. English, Spanish.

12.
13.

The effect of repeated administration of methotrexate (MTX) on rat ovary: measurement of serum antimullerian hormone (AMH) levels.

Benian A, Guralp O, Uzun DD, Okyar A, Sahmay S.

Gynecol Endocrinol. 2013 Mar;29(3):226-9. doi: 10.3109/09513590.2012.738725.

PMID:
23428228
14.

Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate?

de Araujo DB, Yamakami LY, Aikawa NE, Bonfá E, Viana VS, Pasoto SG, Pereira RM, Serafin PC, Borba EF, Silva CA.

Scand J Rheumatol. 2014;43(6):503-11. doi: 10.3109/03009742.2014.908237. Epub 2014 Jun 2.

PMID:
24881927
15.

Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve.

Gleicher N, Weghofer A, Barad DH.

Fertil Steril. 2010 Dec;94(7):2824-7. doi: 10.1016/j.fertnstert.2010.04.067. Epub 2010 Jun 11.

PMID:
20538269
16.

Subclinical impairment of ovarian reserve in systemic lupus erythematosus patients with normal menstruation not using alkylating therapy.

Ma W, Zhan Z, Liang X, Chen J, Huang X, Liao C.

J Womens Health (Larchmt). 2013 Dec;22(12):1023-7. doi: 10.1089/jwh.2013.4255.

17.

Ovarian failure and flares of systemic lupus erythematosus.

Mok CC, Wong RW, Lau CS.

Arthritis Rheum. 1999 Jun;42(6):1274-80.

18.

Age at menarche and parity are independently associated with Anti-Müllerian hormone, a marker of ovarian reserve, in Filipino young adult women.

Bragg JM, Kuzawa CW, Agustin SS, Banerjee MN, McDade TW.

Am J Hum Biol. 2012 Nov-Dec;24(6):739-45. doi: 10.1002/ajhb.22309. Epub 2012 Aug 22.

PMID:
22915230
19.
20.

Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.

Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.

Am J Med. 2006 Apr;119(4):355.e25-33.

PMID:
16564783

Supplemental Content

Support Center